Noer, J B, Talman, M-L M & Moreira, J M A 2021, ' HLA Class II Histocompatibility Antigen gamma Chain (CD74) Expression Is Associated with Immune Cell Infiltration and Favorable Outcome in Breast Cancer ', Cancers, vol. 13, no. 24, 6179 . https://doi.org/10.3390/cancers13246179 Cancers, Vol 13, Iss 6179, p 6179 (2021) Cancers Cancers; Volume 13; Issue 24; Pages: 6179
Christensen, A G, Ehmsen, S, Terp, M G, Batra, R, Alcaraz, N, Baumbach, J, Noer, J B, Moreira, J M A, Leth-Larsen, R, Larsen, M R & Ditzel, H J 2017, ' Elucidation of altered pathways in tumor-initiating cells of triple-negative breast cancer : A useful cell model system for drug screening ', Stem Cells, vol. 35, no. 8, pp. 1898–1912 . https://doi.org/10.1002/stem.2654
Jandu, H, Aluzaite, K, Fogh, L, Thrane, S W, Noer, J B, Proszek, J, Do, K N, Hansen, S N, Damsgaard, B, Nielsen, S L, Stougaard, M, Knudsen, B R, Moreira, J, Hamerlik, P, Gajjar, M, Smid, M, Martens, J, Foekens, J, Pommier, Y, Brünner, N, Schrohl, A-S & Stenvang, J 2016, ' Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines ', BMC Cancer, vol. 16, no. 1, 34 . https://doi.org/10.1186/s12885-016-2071-1 BMC Cancer Jandu, H, Aluzaite, K, Fogh, L, Thrane, S W, Noer, J B, Proszek, J, Nguyen Do, K, Hansen, S N, Damsgaard, B, Nielsen, S L, Stougaard, M, Knudsen, B R, Moreira, J, Hamerlik, P, Gajjar, M, Smid, M, Martens, J, Foekens, J, Pommier, Y, Brunner, N, Schrohl, A-S & Stenvang, J 2016, ' Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines ', B M C Cancer, vol. 16, no. 1, 34 . https://doi.org/10.1186/s12885-016-2071-1 BMC Cancer, 16:34. BioMed Central Ltd.
Tarpgaard, L S, Ørum-Madsen, M S, Christensen, I J, Nordgaard, C, Noer, J, Guren, T K, Glimelius, B, Sorbye, H, Ikdahl, T, Kure, E H, Tveit, K M, Nielsen, H J, Pfeiffer, P, Brünner, N & Moreira, J M A 2016, ' TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells : A potential novel approach to the treatment of metastatic colorectal cancer ', Oncotarget, vol. 7, no. 37, pp. 59441-59457 . https://doi.org/10.18632/oncotarget.11118 Oncotarget